The caller alleged a variance between inratio inr results and the lab inr results.The results were as follows: inratio 2.2; lab 6.5.Physician reports (via distributor) a discrepant low result with one patient on (b)(6) 2015.A patient in (b)(6) visits physician because of blood in his urine.The inratio shows inr = 2.2.The patient is referred to a urologist who refers patient to the hospital.Hospital's lab tests inr = 6.5, the time between the two tests is about four hours.Nurse states that the patient had stable values prior to this time.The patient was hospitalized due to blood in the urine.A follow up call was made with the specialist, dr.(b)(6).The physician stated that the patient is doing well.The preliminary medical report from the hospital does not provide any other medical reason for the bleeding except the elevated inr.The general practitioner will perform inr measurements for this particular patient only in the lab.The specialist, dr.(b)(6) is considering switching the patient's medication over to a doac (direct oral anticoagulant).No further information is available concerning the length of time patient was in the hospital, what treatments he received or what his inr values were.All other comparative measurements of other patients were acceptable.
|
It is indicated that the product is not returning for evaluation.Therefore, in-house testing with the reported lot was performed.In-house testing on strip lot k377620 meets criteria.The product performed as expected.A review of the manufacturing records for lot k377620 did not uncover any non-conformances.Root cause cannot be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|